Showing results (81-90 of 224) with videos related to

Sort By:
Pageof 23
Antiviral Therapy|January 7, 2015
Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudineAndreas Geipel, Pia L Seiz, Hauke Niekamp, et al.
Viruses|April 30, 2021
Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption InhibitorsMichael Kirstgen, Kira Alessandra Alicia Theresa Lowjaga, Simon Franz Müller, et al.
Hepatology (Baltimore, Md.)|December 6, 2012
Myristoylated PreS1-domain of the hepatitis B virus L-protein mediates specific binding to differentiated hepatocytesAnja Meier, Stefan Mehrle, Thomas S Weiss, et al.
Antiviral Therapy|November 15, 2017
Drug-drug interaction potential of the HBV and HDV entry inhibitor myrcludex B assessed in vitroAntje Blank, Katrin Meier, Stephan Urban, et al.
Hepatology (Baltimore, Md.)|February 4, 2023
Hepatitis delta: Epidemiology to recent advances in therapeutic agentsNehna Abdul Majeed, Benno Zehnder, Christopher Koh, et al.
Experimental Cell Research|July 8, 2018
Hepatitis B virus suppresses the secretion of insulin-like growth factor binding protein 1 to facilitate anti-apoptotic IGF-1 effects in HepG2 cellsKirstine Overgaard Nielsen, Aashiq Hussain Mirza, Simranjeet Kaur, et al.
Frontiers in Molecular Biosciences|July 9, 2021
Mutational Analysis of the GXXXG/A Motifs in the Human Na+/Taurocholate Co-Transporting Polypeptide NTCP on Its Bile Acid Transport Function and Hepatitis B/D Virus Receptor FunctionMassimo Palatini, Simon Franz Müller, Kira Alessandra Alicia Theresa Lowjaga, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 3, 2020
Cholestasis impairs hepatic lipid storage via AMPK and CREB signaling in hepatitis B virus surface protein transgenic miceKaruna Irungbam, Martin Roderfeld, Hannah Glimm, et al.
Pageof 23